Open Access
AJP Rep 2013; 03(02): 087-090
DOI: 10.1055/s-0033-1343791
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy

Autoren

  • Christina A. Herrera

    1   Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
  • Kacey Y. Eichelberger

    2   Division of Maternal Fetal Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina
  • Nancy C. Chescheir

    2   Division of Maternal Fetal Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina
Weitere Informationen

Publikationsverlauf

12. Januar 2013

26. Februar 2013

Publikationsdatum:
21. Mai 2013 (online)

Abstract

Fulminant herpes hepatitis with disseminated extrahepatic involvement in pregnancy is rare and carries a high mortality risk. Although acyclovir remains standard first-line therapy, effective management of acyclovir-resistant disseminated herpes simplex virus (HSV) in pregnancy remains elusive. We present a case of disseminated HSV resistant to both acyclovir and foscarnet, the first double-agent resistant case in pregnancy reported in the literature to date. In this case, therapeutic delivery was the ultimate treatment resulting in full recovery.